|
Volumn 30, Issue 4, 2006, Pages 545-547
|
Angiomyxofibromatous tumor of the falx cerebri
|
Author keywords
Angiomyxofibromatous tumor; Dura; Falx cerebri; Soft tissue
|
Indexed keywords
CD34 ANTIGEN;
CYTOKERATIN;
CYTOKERATIN CAM 5.2;
DESMIN;
EPITHELIAL MEMBRANE ANTIGEN;
GLIAL FIBRILLARY ACIDIC PROTEIN;
PROTEIN BCL 2;
PROTEIN MIC2;
PROTEIN S 100;
SMOOTH MUSCLE ACTIN;
TUMOR PROTEIN;
UNCLASSIFIED DRUG;
VIMENTIN;
ADULT;
ANGIOGENESIS;
ANGIOMYXOFIBROMATOUS TUMOR;
ARTICLE;
CASE REPORT;
CLINICAL FEATURE;
DURA MATER;
FEMALE;
HUMAN;
HUMAN TISSUE;
NERVOUS SYSTEM TUMOR;
NUCLEAR MAGNETIC RESONANCE IMAGING;
SPINDLE CELL;
STELLATE CELL;
TUMOR CELL;
TUMOR CLASSIFICATION;
WORLD HEALTH ORGANIZATION;
DISEASE FREE SURVIVAL;
HEMANGIOFIBROMA;
MENINGIOMA;
MIDDLE AGED;
MYXOMA;
PATHOLOGY;
TREATMENT OUTCOME;
ANGIOFIBROMA;
DISEASE-FREE SURVIVAL;
DURA MATER;
FEMALE;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MENINGEAL NEOPLASMS;
MIDDLE AGED;
MYXOMA;
TREATMENT OUTCOME;
|
EID: 33646715342
PISSN: 01475185
EISSN: None
Source Type: Journal
DOI: 10.1097/00000478-200604000-00018 Document Type: Article |
Times cited : (7)
|
References (15)
|